The Missouri Pharmacy Association is examining the latest deal President Trump has reached with the pharmaceutical industry. Nine drug makers — Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi...
A reprieve for prescription drug users, as President Trump has paused placing a 100% tariff on prescription drugs manufactured overseas. Ron Fitzwater, CEO of the Missouri Pharmacy Association, said the tariffs would not have impacted people who use generic drugs....
